货号：UP982024514
| 产品信息 | |
| 产品名称： | R428 (BGB324; Bemcentinib) |
| 中文名称： | R428 (BGB324)(请以英文为准,中文仅做参考) |
| CAS号： | 1037624-75-1 |
| 分子式： | C30H34N8 |
| 分子量： | 506.64 |
| MDL NO： | MFCD21608463 |
| 标准纯度： | 98+% (UP982024514) |
| 沸点： | - |
| 储存： | Keep in dark place,Inert atmosphere,2-8°C (UP982024514) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
Tie-2
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
Syk
抑制剂/受体激动剂
蛋白酪氨酸激酶/受体酪氨酸激酶
Trk Receptor
AZD5582
UP8853078501258392-53-8
Glutaminase C-IN-1
UP429713742311795-38-7
(6a,9a,11b,16a,17a)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid
UP88298388128416-82-2
Rosuvastatin Calcium
UP662871434147098-20-2
IRAK inhibitor 2
UP853777381928333-30-6
Atorvastatin
UP318441597134523-00-5
Ac-L-Gln-OH
UP1561928602490-97-3
Loxapine succinate salt
UP61581231627833-64-3
1-Cyclopropylbutane-1,3-dione
UP19765407121573-10-4
2-Methylindole
UP77033872995-20-5
AGN 205728
UP740726609859498-05-8
Sulcotrione
UP77806922499105-77-8
4-Bromo-1H-pyrazole
UP4910674222075-45-8
Embelin
UP956245084550-24-3
U-74389G
UP926746713153190-29-5
PF-06827443
UP9031366942115022-67-6
2-Methyl-5-nitro-1H-imidazole
UP234076264696-23-1
PHA-543613 Dihydrochloride
UP418249829478148-58-2
Pirenzepine dihydrochloride
UP48114514829868-97-1
Flavoxate Hydrochloride
UP2521516383717-88-2
N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-methylacetamide
UP98934195796605-65-1
STING agonist-1
UP459591616702662-50-8
HSP990
UP508139722934343-74-5
Maraviroc
UP796188212376348-65-1
T-5224
UP539597604530141-72-1
Ethyl 1-aminocyclopentanecarboxylate
UP7668351191664-35-3
(2R,3R,4S,5R)-2-(6-Chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
UP8721129475399-87-1
ATN-224
UP335334755649749-10-0
Mebhydrolin napadisylate
UP4585826786153-33-9
Lafutidine
UP616439555118288-08-7
3-Bromo-4-fluorochlorobenzene
UP2804166871996-30-1
Etomidate hydrochloride
UP56505241153188-20-8
(Diethoxyphosphoryl)methyl 4-methylbenzenesulfonate
UP80503434931618-90-3
AGI-5198
UP1355726591355326-35-0
ML RR-S2 CDA
UP7073019321638241-89-0
Eptifibatide
UP404659872188627-80-7
2-Methyl-1-phenylbutane-1,3-dione
UP8478354316668-24-2
Nimesulide
UP41024937351803-78-2
FL118
UP767663229151636-76-9
VU 0255035
UP3563348861135243-19-4
Pitavastatin
UP906184279147511-69-1
GTS-21 dihydrochloride
UP868252951156223-05-1
YM-155 hydrochloride
UP263151238355406-09-6
Acitretin
UP28135547655079-83-9
MK-0812
UP714861291624733-88-6
Pifithrin-β hydrobromide
UP218557600511296-88-1
Cevimeline hydrochloride hemihydrate
UP729916698153504-70-2
AIM-100
UP331129707873305-35-2
CWHM-12
UP5551495681564286-55-0
LCL161
UP9967465781005342-46-0
Basic Orange 14
UP50123938110127-02-3
EVP-6124
UP201262590550999-75-2
TR-14035
UP920907007232271-19-1
Ketotifen fumarate
UP43459579334580-14-8
SGI-7079
UP1187953981239875-86-5
WZ811
UP30823156455778-02-4
Napabucasin
UP37343836483280-65-3
Luminespib
UP454845076747412-49-3
Sivelestat
UP563488026127373-66-4
R428 (BGB324; Bemcentinib)
UP9820245141037624-75-1